Supplemental material
Emerging Microbes & Infections
Volume 11, 2022 - Issue 1
Open access
3,258
Views
6
CrossRef citations to date
0
Altmetric
Coronaviruses
Etesevimab in combination with JS026 neutralizing SARS-CoV-2 and its variants
Fengze Wanga CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People’s Republic of China;b University of Chinese Academy of Sciences, Beijing, People’s Republic of ChinaView further author information
, Li Lic Shanghai Junshi Biosciences Co. Ltd, Shanghai, People’s Republic of ChinaView further author information
, Yang Doud School of Pharmaceutical Sciences, IDG/McGovern Institute for Brain Research, Tsinghua University, Beijing, People’s Republic of ChinaView further author information
, Rui Shia CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People’s Republic of ChinaView further author information
, Xiaomin Duana CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People’s Republic of China;b University of Chinese Academy of Sciences, Beijing, People’s Republic of ChinaView further author information
, Hongchuan Liuc Shanghai Junshi Biosciences Co. Ltd, Shanghai, People’s Republic of ChinaView further author information
, Jing Zhangc Shanghai Junshi Biosciences Co. Ltd, Shanghai, People’s Republic of ChinaView further author information
, DanDan Liuc Shanghai Junshi Biosciences Co. Ltd, Shanghai, People’s Republic of ChinaView further author information
, Jing Wuc Shanghai Junshi Biosciences Co. Ltd, Shanghai, People’s Republic of ChinaView further author information
, Yang Hec Shanghai Junshi Biosciences Co. Ltd, Shanghai, People’s Republic of ChinaView further author information
, Jun Lane Beijing Advanced Innovation Center for Structural Biology, School of Life Sciences, Tsinghua University, Beijing, People’s Republic of ChinaView further author information
, Bai Lud School of Pharmaceutical Sciences, IDG/McGovern Institute for Brain Research, Tsinghua University, Beijing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
, View further author information
Hui Fengc Shanghai Junshi Biosciences Co. Ltd, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
View further author information
& View further author information
Jinghua Yana CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People’s Republic of China;b University of Chinese Academy of Sciences, Beijing, People’s Republic of ChinaCorrespondence[email protected]
https://orcid.org/0000-0003-0502-3829View further author information
Pages 548-551
|
Received 06 Dec 2021, Accepted 19 Jan 2022, Published online: 10 Feb 2022
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.